NCT00691652 2019-11-27Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaOHSU Knight Cancer InstitutePhase 1/2 Terminated2 enrolled 4 charts
NCT00055640 2010-06-10Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's LymphomaCase Comprehensive Cancer CenterPhase 2 Completed9 enrolled